A Pilot Study to Explore the Role of Gut Flora in Gout
NCT04224662 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Conditions
Interventions
- OTHER
-
No intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
NCT03636373 ·Status: TERMINATED ·Phase: PHASE4
-
Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions
NCT02903446 ·Status: COMPLETED ·Phase: PHASE2
-
Genetics of Hyperuricemia Therapy in Hmong
NCT02371421 ·Status: COMPLETED
-
Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant
NCT04087720 ·Status: COMPLETED ·Phase: PHASE4
-
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
NCT00675103 ·Status: COMPLETED ·Phase: PHASE3
-
Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
NCT04511702 ·Status: COMPLETED ·Phase: PHASE4
-
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
NCT06622603 ·Status: RECRUITING ·Phase: PHASE4
-
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
NCT05522504 ·Status: ACTIVE_NOT_RECRUITING
-
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560 ·Status: COMPLETED
-
MPC-004 for the Treatment of an Acute Gout Flare
NCT00506883 ·Status: COMPLETED ·Phase: PHASE3
-
Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy
NCT04772313 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
Gout Self-Monitoring Aiming to Reach Target
NCT03274063 ·Status: COMPLETED ·Phase: NA
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
NCT04987294 ·Status: TERMINATED ·Phase: PHASE2
-
GOS and the Management of Hyperuricemia
NCT06630377 ·Status: RECRUITING ·Phase: NA
-
Open-Label Lesinurad Monotherapy Extension Study in Gout
NCT01650246 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)
NCT04762498 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
NCT06270225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
NCT05665699 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)
NCT00142558 ·Status: COMPLETED ·Phase: PHASE4
-
Does Allopurinol Prolong a Treated, Acute Gout Flare?
NCT01988402 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of Genakumab for Injection in Patients With Acute Gout
NCT05328531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2